logo

Chemocentryx Inc. (CCXI)



Trade CCXI now with
  Date
  Headline
1/24/2019 8:41:52 AM ChemoCentryx Reports Withdrawal Of Phase II-Based CMA Application For ANCA-Associated Vasculitis In Europe
9/27/2018 10:35:16 PM ChemoCentryx Says Not To Proceed With Public Offering
9/26/2018 4:09:07 PM ChemoCentryx Announces Proposed Public Offering Of Common Stock
3/9/2018 7:16:36 AM ChemoCentryx Q4 Net Income $39.7 Mln Vs Net Loss $7.7 Mln Last Year
1/8/2018 8:37:31 AM ChemoCentryx Appoints William Fairey As EVP And COO
1/4/2018 7:04:14 AM ChemoCentryx To Receive Regulatory Milestone Payment From VFMCRP
  
 
>